Market research
F02.F FLEXION THERAPEUTICS INC
F EUR Other
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 404M
- P/E ratio
- Not available
- Analyst target
- Not available
- Dividend yield
- 0.0%
- Beta
- Not available
Community
Investor discussion
1 comment
Sign in to join the F02.F discussion.
5 years, 5 months ago
FLEXION THERAPEUTICS INC is currently in a long term downtrend where the price is trading 26.1% below its 200 day moving average.
From a valuation standpoint, the stock is 61.4% cheaper than other stocks from the Other sector with a price to sales ratio of 4.9.
FLEXION THERAPEUTICS INC's total revenue rose by 11.2% to $26M since the same quarter in the previous year.
Its net income has increased by 41.4% to $-20M since the same quarter in the previous year.
Finally, its free cash flow grew by 73.7% to $-11M since the same quarter in the previous year.
Based on the above factors, FLEXION THERAPEUTICS INC gets an overall score of 4/5.